These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 43754)

  • 21. Tardive dyskinesia in schizophrenic patients: correlation with negative symptoms.
    Bartzokis G; Hill MA; Altshuler L; Cummings JL; Wirshing W; May PR
    Psychiatry Res; 1989 May; 28(2):145-51. PubMed ID: 2568650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.
    Rapaport MH; Lohr JB
    Acta Psychiatr Scand; 1994 Nov; 90(5):311-5. PubMed ID: 7872033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
    Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K
    Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms.
    Pantelis C; Stuart GW; Nelson HE; Robbins TW; Barnes TR
    Am J Psychiatry; 2001 Aug; 158(8):1276-85. PubMed ID: 11481163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic-induced parkinsonism in older schizophrenics.
    Hoffman WF; Labs SM; Casey DE
    Biol Psychiatry; 1987 Apr; 22(4):427-39. PubMed ID: 2882787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comment on "tardive dyskinesia circa 2006".
    Rosenheck RA
    Am J Psychiatry; 2007 Jan; 164(1):170; author reply 170. PubMed ID: 17202564
    [No Abstract]   [Full Text] [Related]  

  • 29. Late onset involuntary movements in chronic schizophrenia: relationship of 'tardive' dyskinesia to intellectual impairment and negative symptoms.
    Waddington JL; Youssef HA
    Br J Psychiatry; 1986 Nov; 149():616-20. PubMed ID: 2880630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prediction of chronic persistent versus intermittent tardive dyskinesia. A retrospective follow-up study.
    Glazer WM; Morgenstern H; Doucette JT
    Br J Psychiatry; 1991 Jun; 158():822-8. PubMed ID: 1678663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dyskinesia and neuroleptic exposure in elderly psychiatric inpatients.
    Sweet RA; Mulsant BH; Rifai AH; Zubenko GS
    J Geriatr Psychiatry Neurol; 1992; 5(3):156-61. PubMed ID: 1353963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of clozapine on preexisting tardive dyskinesia.
    Littrell K; Magill AM
    J Psychosoc Nurs Ment Health Serv; 1993 Sep; 31(9):14-8. PubMed ID: 7901407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW; White T
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics.
    Altamura AC; Cavallaro R; Regazzetti MG
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(1):9-12. PubMed ID: 1979540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI abnormalities in tardive dyskinesia.
    Mion CC; Andreasen NC; Arndt S; Swayze VW; Cohen GA
    Psychiatry Res; 1991 Nov; 40(3):157-66. PubMed ID: 1685788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia.
    Waddington JL; Youssef HA; Kinsella A
    Psychol Med; 1990 Nov; 20(4):835-42. PubMed ID: 1980953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical correlates of neurological soft signs in chronic schizophrenia.
    King DJ; Wilson A; Cooper SJ; Waddington JL
    Br J Psychiatry; 1991 Jun; 158():770-5. PubMed ID: 1678661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is tardive dyskinesia a unique disorder?
    Marsden CD
    Psychopharmacology Suppl; 1985; 2():64-71. PubMed ID: 2860661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schizophrenics with tardive dyskinesia. Neuropsychological deficit and family psychopathology.
    Wegner JT; Catalano F; Gibralter J; Kane JM
    Arch Gen Psychiatry; 1985 Sep; 42(9):860-5. PubMed ID: 2864029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.